Rapid Progressing Allele HLA-B35 Px Restricted Anti-HIV-1 CD8+ T Cells Recognize Vestigial CTL Epitopes

• Christian B. Willberg,

  Affiliation Division of Experimental Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Keith E. Garrison,

  Affiliation Division of Experimental Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• R. Brad Jones,

  Affiliation Department of Immunology, University of Toronto, Toronto, Ontario, Canada

  ⨯
• Duncan J. Meiklejohn,

  Affiliation Division of Experimental Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Gerald Spotts,

  Affiliation Division of HIV/AIDS, Department of Medicine, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Teri J. Liegler,

  Affiliation Division of HIV/AIDS, Department of Medicine, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Mario A. Ostrowski,

  Affiliation Department of Immunology, University of Toronto, Toronto, Ontario, Canada

  ⨯
• Annika C. Karlsson,

  Affiliations Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Solna, Sweden, Department of Virology, The Swedish Institute for Infectious Disease Control, Solna, Sweden

  ⨯
• Frederick M. Hecht,

  Affiliation Division of HIV/AIDS, Department of Medicine, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Douglas F. Nixon

  * E-mail: douglas.nixon@ucsf.edu

  Affiliation Division of Experimental Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, United States of America

  ⨯